Sheila Gujrathi Insider Trading $TPTX Turning Point Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sheila Gujrathi.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sheila Gujrathi. Sheila Gujrathi is Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Chief Medical Officer in Receptos, Inc. ($RCPT) and Director in Turning Point Therapeutics, Inc. ($TPTX) and President & CEO in Gossamer Bio, Inc. ($GOSS).

Sheila Gujrathi in Turning Point Therapeutics, Inc.

Trading Symbol: TPTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sheila Gujrathi: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Sheila Gujrathi in Turning Point Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FPRX, GOSS, RCPT, TPTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 17 2020TPTXTurning Point Ther ...Gujrathi SheilaDirectorOption ExerciseA65.398,500555,8158,500
Apr 24 2019TPTXTurning Point Ther ...Gujrathi SheilaDirectorOption ExerciseA27.0615,000405,90015,000

Page:   1